Education
About Us
Working with TipRanks
Follow Us
Thomas Wessel Insider Profile
4 Followers
Thomas Wessel, CMO at Decoy Therapeutics, holds 37.06K shares in Decoy Therapeutics (Ticker: DCOY), holds 36.35K shares in Acorda Therapeutics (Ticker: ACORQ). Most recently, Thomas Wessel Bought ― shares of Decoy Therapeutics on Mar 15, 2016 for an estimated value of $158.84K.
Thomas Wessel has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Roles
CMO
Roles that Thomas Wessel holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Thomas Wessel
Thomas Wessel's Trading History
Decoy Therapeutics
Mar 15, 2016
CMO
Informative Buy
158.84K
$24.50K
Acorda Therapeutics
Mar 07, 2011
―
Uninformative Buy
―
$472.55
List of latest transactions for each holding click on a transaction to see Thomas Wessel's performance on stock
You May Also Like
Thomas Wessel insider profile FAQ
What is the percentage of profitable transactions made by Thomas Wessel?
The percentage of profitable transactions made by Thomas Wessel is ―.
What is the average return per transaction made by Thomas Wessel?
The average return per transaction made by Thomas Wessel is ―.
What stocks does Thomas Wessel hold?
Thomas Wessel holds: DCOY, ACORQ stocks.
What was Thomas Wessel’s latest transaction?
Thomas Wessel latest transaction was an Informative Buy of $158.84K.
What was Thomas Wessel's most profitable transaction?
Thomas Wessel’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Thomas Wessel's role in Decoy Therapeutics?
Thomas Wessel's role in Decoy Therapeutics is CMO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.